Eisai (AcipHex Rights for the United States Market) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Eisai (AcipHex Rights for the United States Market) General Information

Description

Rights based in United States.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • United States
Primary Industry
Buildings and Property
Corporate Office
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Eisai (AcipHex Rights for the United States Market) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Eisai (AcipHex Rights for the United States Market)‘s full profile, request access.

Request a free trial

Eisai (AcipHex Rights for the United States Market) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Eisai (AcipHex Rights for the United States Market)‘s full profile, request access.

Request a free trial

Eisai (AcipHex Rights for the United States Market) FAQs

  • Where is Eisai (AcipHex Rights for the United States Market) headquartered?

    Eisai (AcipHex Rights for the United States Market) is headquartered in .

  • What industry is Eisai (AcipHex Rights for the United States Market) in?

    Eisai (AcipHex Rights for the United States Market)’s primary industry is Buildings and Property.

  • Is Eisai (AcipHex Rights for the United States Market) a private or public company?

    Eisai (AcipHex Rights for the United States Market) is a Private company.

  • What is Eisai (AcipHex Rights for the United States Market)’s current revenue?

    The current revenue for Eisai (AcipHex Rights for the United States Market) is .

  • Who are Eisai (AcipHex Rights for the United States Market)’s investors?

    Eisai has invested in Eisai (AcipHex Rights for the United States Market).

  • When was Eisai (AcipHex Rights for the United States Market) acquired?

    Eisai (AcipHex Rights for the United States Market) was acquired on 21-Nov-2021.

  • Who acquired Eisai (AcipHex Rights for the United States Market)?

    Eisai (AcipHex Rights for the United States Market) was acquired by Woodward Pharma Services.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process